Submit Your Best Content to ISPE

ISPE’s official blog, iSpeak accepts contributions from our Members and professionals in the pharma industry.  

What We Look For 

iSpeak Blog

P&ID walk-downs are a critical activity during commissioning and qualification (C&Q) turnover, ensuring that physical installations align with the design intent. Traditionally, this process relies on manual checks using printed drawings, which is labor-intensive and prone to human error. Although digital platforms exist across design, engineering, construction and turnover...

iSpeak Blog

In 2020, CSL initiated a benchmarking activity with a small group of peer companies identified through ISPE to explore creation and maturation of Asset Management programs at each company. The initial sessions were a success, covering topics such as Asset Condition Evaluations and Asset Management Governance. CSL was keen to continue the conversations and gather more insights on certain...

iSpeak Blog

ISPE has once again assembled the most comprehensive industry conference on aseptic manufacturing that all should attend. The planning committee began their efforts within days of last year’s outstanding conference, with this year’s building upon the learning of last year. The speakers at this year’s conference are shaping the future of aseptic processing and sterile manufacturing. The

iSpeak Blog

Pharmaceutical companies have changed their operational model to meet the growing demand for complex biopharmaceuticals. These changes have allowed the pharmaceutical industry to deliver more than just the most efficient and sustainable solutions. Beyond efficiency, the pharmaceutical industry has begun leveraging advanced technologies to reshape the drug discovery and development process...

iSpeak Blog

Two members of the International Society for Pharmaceutical Engineering (ISPE) participated in a recent workshop organized by the National Academies of Sciences, Engineering, and Medicine (NASEM). The event, titled Improving Resiliency in the U.S. Pharmaceutical Supply Chain Through Make-Buy-Invest Strategic Actions, was held on 22–23 October in Washington, D.C., USA, and via remote access....

iSpeak Blog

On 20–21 October 2025, ISPE’s Enabling Pharmaceutical Innovation initiative team partnered with Brazil’s National Health Surveillance Agency (ANVISA) to host a workshop focused on innovation and regulatory harmonization in Latin America. The event aimed to explore opportunities for industry to work together with ANVISA and other health authorities to reduce obstacles and encourage innovative...

iSpeak Blog
ISPE was founded in 1980 to create a collaborative space for life sciences professionals to connect, share knowledge, and innovate to advance the industry. Over 45 years, ISPE has evolved from an idea into a global community focused on knowledge advancement, raising the benchmark for industry standards, and inspiring excellence. ISPE guides industry practices, supports innovation, and fosters...
iSpeak Blog

Laboratories are among the most resource-intensive environments, consuming large amounts of energy, water, and chemicals while providing much needed healthcare solutions to the community. It is important that an organization’s focus on go green initiatives trickles down all the way to how the laboratories handle their reagents, consumables, their instruments, laboratory process while...

iSpeak Blog

Pharmaceutical manufacturing is at a turning point. For decades, large-scale centralized facilities have been the backbone of medicine production, but today’s healthcare landscape demands something different: flexibility and personalization. Patients need therapies that are accessible anywhere, tailored to individual needs, and produced with resiliency against shortages. Emerging models like...

iSpeak Blog

On the final day of the 2025 ISPE Annual Meeting & Expo, regulators and senior industry leaders convened for the Global Regulatory Town Hall—a long-standing and popular feature of the annual event. The discussion focused on the growing impact of digitalization and the increasing use of artificial intelligence (AI) by both regulators and industry. The session featured a mix of pre-prepared...

Subscribe to ISPE ISpeak Blogs